Page last updated: 2024-10-24

chlorambucil and Genome Instability

chlorambucil has been researched along with Genome Instability in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mangerich, A1
Debiak, M1
Birtel, M1
Ponath, V1
Balszuweit, F1
Lex, K1
Martello, R1
Burckhardt-Boer, W1
Strobelt, R1
Siegert, M1
Thiermann, H1
Steinritz, D1
Schmidt, A1
Bürkle, A1

Other Studies

1 other study available for chlorambucil and Genome Instability

ArticleYear
Sulfur and nitrogen mustards induce characteristic poly(ADP-ribosyl)ation responses in HaCaT keratinocytes with distinctive cellular consequences.
    Toxicology letters, 2016, Feb-26, Volume: 244

    Topics: Adenosine Diphosphate Ribose; Antidotes; Antineoplastic Agents, Alkylating; Cell Line; Cell Prolifer

2016